New York, NY -- The Damon Runyon Cancer Research Foundation named 18 new Damon Runyon Fellows at its May 2007 Scientific Advisory Committee review. The recipients of this prestigious, three-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Fellowship is specifically intended to encourage the nation's most promising young investigators to pursue careers in cancer research by providing them with independent funding to work on innovative projects. The Damon Runyon Cancer Research Foundation has committed more than $140 million to support the careers of cancer researchers across the United States since the programs inception.
2007 Damon Runyon Fellows
Danielle S.W. Benoit, PhD, with her sponsor Patrick S. Stayton, PhD, at the University of Washington, Seattle, Washington, is developing novel drug delivery systems for a new class of biomolecular anti-cancer agents called siRNAs.
Maya Capelson, PhD, with her sponsor Martin W. Hetzer, PhD, at The Salk Institute for Biological Studies, La Jolla, California, is investigating the role of gene gates or nuclear pores in tumor formation and cancer progression.
Lea A. Goentoro, PhD, with her sponsor Marc W. Kirschner, PhD, at Harvard Medical School, Boston, Massachusetts, is looking for clues as to how a key regulator of cell-to-cell communication commonly mutated in colon, liver, skin, and ovarian cancers called the Wnt pathway, transmits signals.
Michael D. Gordon, PhD, with his sponsor Kristin Scott, PhD, at the University of California, Berkeley, California, is defining the neural circuits that control feeding - providing fundamental knowledge to frame the growing health crisis of obesity.
Ryan C. Heller, PhD, with his sponsor Stephen P. Bell, PhD, at the Massachusetts Institute of Technology, Cambridge, Massachusetts, is identifying the determinants of p
'"/>
Contact: Jennifer McCafferty-Cepero
jennifer.mccafferty@drcrf.org
212-455-0520
Damon Runyon Cancer Research Foundation
27-Jun-2007